There is no advantage in increasing the dose of tenecteplase beyond 0.25 mg/kg, the dose most often used for stroke management in Australia and that recommended by local clinical guidelines. In research presented at the recent American Stroke Association’s International Stroke Conference 2020 in Los Angeles and concurrently published in JAMA, 300 ischaemic stroke patients ...
Prof Bruce Campbell: tenecteplase RCT backs up Aussie stroke guidance
By Mardi Chapman
27 Feb 2020